Related Experiment Video
Updated: Jun 14, 2026
Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
Published on: October 17, 2018
Abstract:
Brain microbleeds are small dot-like lesions appearing as hyposignal on gradient echo T2* MR sequences. They represent microscopic areas of old haemosiderin deposits. They are frequent in the setting of symptomatic cerebrovascular disease and also in older healthy people, suggesting a link with cerebral amyloid angiopathy. Their use as diagnostic or prognostic biomarkers remains uncertain. More recently, they have been highlighted as a potential key factor in the pathogenesis of Alzheimer's disease, connecting the main pathological contributors of amyloid accumulation and cerebrovascular damage. The increasing use of MRI in clinical practice and research has brought brain microbleeds very much to our attention, raising many clinical dilemmas, such as-what do they mean? Should I treat a patient with antithrombotic drugs or thrombolysis? And many others.
Insights
Brain microbleeds, often seen on MRI, are linked to Alzheimer's disease and cerebrovascular issues. Their role as biomarkers and treatment implications require further investigation.
Area of Science:
- Neurology
- Radiology
- Pathology
Background:
- Brain microbleeds are small lesions detected by gradient echo T2* MR sequences.
- They indicate microscopic areas of haemosiderin deposits, often associated with cerebrovascular disease and aging.
- A potential link exists between microbleeds and cerebral amyloid angiopathy.
Purpose of the Study:
- To explore the significance of brain microbleeds in Alzheimer's disease pathogenesis.
- To investigate the connection between microbleeds, amyloid accumulation, and cerebrovascular damage.
- To address clinical dilemmas regarding the interpretation and management of brain microbleeds.
Main Methods:
- Gradient echo T2* Magnetic Resonance Imaging (MRI) sequences are utilized for detection.
- Observational studies likely involved patient cohorts with cerebrovascular disease and/or Alzheimer's disease.
- Analysis of pathological correlates, such as haemosiderin deposits, is implied.
Main Results:
- Brain microbleeds are frequently observed in patients with symptomatic cerebrovascular disease and in older individuals.
- They are increasingly recognized as a potential key factor in Alzheimer's disease.
- The diagnostic and prognostic utility of brain microbleeds as biomarkers is currently uncertain.
Conclusions:
- Brain microbleeds represent an important finding in neuroimaging, linking amyloid pathology and cerebrovascular damage.
- Further research is needed to clarify their role in disease progression and therapeutic strategies.
- Clinical management decisions, including the use of antithrombotic or thrombolytic drugs, require careful consideration in the presence of brain microbleeds.
Related Concept Videos
01:17Hemorrhagic Stroke l: Introduction
01:29Hemorrhagic Stroke ll: Pathophysiology